Incyte Corp (NASDAQ:INCY) currently has a daily average trading volume of 2.09M but it saw 1577488 shares traded in last market. With a market cap of 13.05B USD, the company’s current market price of $67.42 came rising about 0.46 while comparing to the previous closing price of $67.11. In past 52 weeks, the stock remained buoying in the range of price level as high as $83.95 and as low as $53.56.
UBS issued its recommendations for the stock as it initiated the price target for the stock is $77.
Over the week, INCY’s stock price is moving 3.83% up while it is 8.55% when we observe its performance for the past one month. Year-to-date it is -2.39% down and over the past year, the stock is showing an upside performance of 16.66%.
The company is expected to be releasing its next quarterly report in July, for which analysts forecasted an EPS of 1.4 while estimate for next year EPS is 5.83. In next quarter, company is expected to be making quarterly sales of $1.22B as analysts are expecting the sales for current fiscal year at $4.7B and seeing the company making $5.17B in sales next year. Moreover, analysts are in estimates of $1.15B for current-quarter revenue.
Currently, Incyte Corp’s total number of outstanding shares is 193.78M with 2.22% of that held by the insiders while 100.56% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 0.57% and return on equity (ROE) at 0.47%. It has a price to earnings ratio (P/E ratio) of 208.60 while having a 10.03 of forward P/E ratio. Stock’s beta reads 0.68. Stock has a price to book (P/B) ratio of 3.56 while price to sale or P/S ratio amounts to 2.96. Its return on asset (ROA) is 0.33% on average.
